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Misinformation and lack of knowledge 
hinder cervical cancer prevention
To the Editor: Cervical cancer is the second most common 
cancer, with an age-standardised incidence rate of 30 per  
100 000 per year, and is the leading cause of cancer mortality 
among South African women.1 The National Department 
of Health (NDOH) national screening policy entitles every 
woman attending public sector services to 3 free Papanicolaou 
(Pap) smears in her lifetime at 10-year intervals, starting 
at the age of 30 years. Properly implemented, this policy 
could decrease the incidence of cervical cancer by more than 
50%. Community awareness is the key to achieving optimal 
coverage and participation in the screening programme.
The causative link between high-risk human papillomavirus 
(HPV) and cervical cancer has been established.2 HPV vaccine 
offers great potential for primary prevention of cervical cancer 
in South Africa. Two prophylactic vaccines, with a good 
safety profile and sustained efficacy after 5 years,3,4 have been 
licensed for use in South Africa but are not yet available in the 
public health sector. Secondary prevention of cervical cancer 
through Pap smears remains vitally important as all women 
will not be vaccinated, some cervical cancers are caused by 
HPV types not included in the current HPV vaccines, and the 
vaccines are not effective in women who already have HPV 
infection.
We conducted a qualitative study between February 2007 
and March 2008 that explored key challenges and opinions 
towards HPV vaccination introduction in South Africa in 
three diverse areas in the Western Cape province. Health care 
providers, policy makers and key policy influentials at national 
and provincial levels were interviewed, and focus group 
discussions were carried out with women aged 21 - 57 years 
who had children who would be eligible for the HPV vaccine.5 
Knowledge and perceptions on cervical cancer and prevention 
were also explored.
Women’s levels of knowledge and understanding of 
cervical cancer, the causative relationship between HPV and 
cervical cancer, and the purpose and preventive nature of Pap 
smears was poor. Many knew of the availability of cervical 
screening services but did not fully understand the purpose 
of Pap smears. Some associated Pap smears with ‘cleansing 
or scraping the womb’, after possible exposure to a sexually 
transmitted infection, after having been raped or, in other 
instances, to ensure fertility. Health care providers confirmed 
some of these beliefs.
Health care providers displayed differing levels of 
knowledge of the current cervical screening policy, the 
rationale for the policy, and the links between HPV and 
cervical cancer. Some providers were misinformed about the 
South African cervical screening policy.
Lack of knowledge of cervical cancer is a prime barrier to 
preventing cervical cancer.6 We need to develop and evaluate 
innovative strategies to raise awareness about cervical cancer 
and the importance of screening as a preventive measure. 
For successful screening programmes, health care providers 
must understand the rationale of policy and the causative 
relationship between HPV and cervical cancer, and be 
cognisant of community misconceptions and beliefs.
J Moodley
J Harries
Women’s Health Research Unit
School of Public Health and Family Medicine
University of Cape Town
jennifer.moodley@uct.ac.za
M Barone
EngenderHealth
New York
USA
1.    Mqoqi N, Kellet P, Madhoo J, Sitas F. Cancer in South Africa, 1996-1997. Johannesburg: National 
Cancer Registry of South Africa, National Health Laboratory Service, 2003.
2.    Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of 
invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
3.    Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 
virus-like particle vaccine against human papillomavirus types 16 and 18: follow up from a 
randomised control trial. Lancet 2006; 367: 1247-1255.
4.    The Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent 
high-grade cervical lesions. N Engl J Med 2007; 356: 1915-1927.
5.    Harries J, Moodley J, Barone MA, Mall S, Sinanovic E. Preparing for HPV vaccination in South 
Africa: Key challenges and opinions. Vaccine 2009; 27(1): 38-44.
6.    Abrahams N, Wood, K, Jewkes R. Barriers to cervical screening: women’s and health workers’ 
perceptions. Curationis 1997; 20(1): 50-52.
Complaints against doctors
To the Editor: The ‘patients corner’ in the South African 
Medical Association website prominently displays the 
following:
COMPLAINTS AGAINST DOCTORS:
 The Health Professions Council of South Africa (HPCSA) 
investigates complaints against medical practitioners on 
behalf of the public.
Complaints must be lodged in writing to:
The Registrar 
Health Professions Council of SA
PO Box 205
PRETORIA
0001
or on their website: www.hpcsa.co.za.
Of course the HPCSA accepts complaints. So do litigation 
lawyers, medical aid societies, fraud lines, consumer columns 
and the South African Police Services. The South African 
Medical Association at branch level also has an established 
structure to deal with complaints.
What possible reason has SAMA to prompt complainants 
to ‘mainline’ to the HPCSA, knowing full well the time lags, 
complexities and costs of defending at HPCSA level, imposing 
(as it does) considerable duress upon SAMA’s members? 
The foundation principle in resolving a dispute is to attempt 
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